Abstract:ABSTRACT Staphylococcus aureus is a leading cause of healthcare-associated infections globally. Vancomycin-resistant S. aureus (VRSA), those with high-level resistance [minimum inhibitory concentration (MIC) of 16–32 μg/mL vancomycin], are uncommon, whereas vancomycin-intermediate S. aureus (VISA; MIC of 4–8 μg/mL), are isolated more frequently and develop during long-term and/or repeated use of the antibiotic. VISA can be difficult to eradicate and infections may persist. Our knowledge of mechanisms that underlie the development of VISA is incomplete. We used a genomics approach to investigate the VISA phenotype in three prominent S. aureus lineages. All VISA clinical isolates tested had increased cell wall thickness compared with vancomycin-susceptible S. aureus strains. Growth rates of clonal complex (CC) 5, CC8, and CC45 clinical isolates were reduced in 2 μg/mL vancomycin compared to media alone. Culture in 2 and 4 μg/mL vancomycin sequentially for two weeks reduced susceptibility to daptomycin, televancin, tigecycline, and vancomycin in a majority of CC5, CC8, and CC45 isolates tested. We identified alleles reported previously to contribute to the VISA phenotype, but unexpectedly, these alleles were unique to each CC. A subtherapeutic concentration of vancomycin elicited changes in the VISA transcriptome—common and unique—among the three CCs tested. Multiple genes, including those encoding a glycerate kinase, an M50 family metallopeptidase, and an uncharacterized membrane protein, were upregulated among all three lineages and not reported previously as associated with VISA. Although there are lineage-specific changes in DNA sequence, our findings suggest changes in the VISA transcriptome constitute a general response to stress that confers reduced susceptibility to multiple antibiotics. IMPORTANCE Our understanding of the mechanisms that underlie the development of vancomycin-intermediate Staphylococcus aureus (VISA) is incomplete. To provide a more comprehensive view of this process, we compared genome sequences of clonal complex (CC) 5, CC8, and CC45 VISA clinical isolates and measured changes in the transcriptomes of these isolates during culture with a subtherapeutic concentration of vancomycin. Notably, we identified differentially expressed genes that were lineage-specific or common to the lineages tested, including genes that have not been previously reported to contribute to a VISA phenotype. Changes in gene expression were accompanied by reduced growth rate, increased cell wall thickness, and reduced susceptibility to daptomycin, televancin, tigecycline, and vancomycin. Our results provide support to the idea that changes in gene expression contribute to the development of VISA among three CCs that are a prominent cause of human infections.

In vitro induction of resistance in Staphylococcus aureus to vancomycin and the susceptibility of other antibiotics against the vancomycin-resistant S.aureus

Investigation of Virulence Genes and Resistance Genes in a Group of Staphylococcus Aureus Isolated in Yuhang, China

The Mechanism Exploration of Vancomycin Resistant Staphylococcus Aureus

Evaluation of methods for detecting susceptibility of Staphylococcus aureus to Vancomycin

Staphylococcus aureus response and adaptation to vancomycin

Biological Characteristic of Vancomycin-Resistant Staphylococcus Aureus

Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10

Study on the in vitro antibacterial activities of the antibacterial drugs against methicillin resistant coagulase-negative staphylococci

Repeated Exposure of Vancomycin to Vancomycin-Susceptible Staphylococcus aureus (VSSA) Parent Emerged VISA and VRSA Strains with Enhanced Virulence Potentials

The Relationship Between the Thickening of Cell Wall and Vancomycin Resistance of Staphylococcus Aureus

Adaptive physiological and metabolic alterations in Staphylococcus aureus evolution under vancomycin exposure

Study on the Virulome and Resistome of a Vancomycin Intermediate-Resistance Staphylococcus Aureus

Misidentification of Vancomycin-Resistant Staphylococcus Aureus As Coagulase-Negative Staphylococcus

Impact of Heteroresistant Vancomycin Intermediate Staphylococcus Aureus on Antimicrobial Therapy of Bacterial Infections

[A Study on the Mechanism of Drug Resistance in Staphylococcus Aureus].

Insights into the molecular basis of reduced vancomycin susceptibility among three prominent Staphylococcus aureus clonal complexes

An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2

Biological characteristics of lysostaphin-resistant Staphylococcus aureus variants induced by recombinant lysostaphin in vit ro

In vitro antimicrobial susceptibility and virulence genes of the Staphylococcus aureus strains isolated from blood and sterile body fluids

Vancomycin Resistance in Enterococcus and Staphylococcus aureus

Mechanisms of Staphylococcus Aureus Antibiotics Resistance Revealed by Adaptive Laboratory Evolution